Skip to main content
. 2012 Dec 10;31(3):314–320. doi: 10.1200/JCO.2012.42.4101

Fig 2.

Fig 2.

Design of Southwest Oncology Group Protocol S0016. (A) Schema for patients randomly assigned to six cycles of cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy with six doses of rituximab (CHOP-R). (B) Schema for patients randomly assigned to six cycles of cyclophosphamide, doxorubicin, vincristine, prednisone chemotherapy followed by consolidation with tositumomab/131I-tositumomab radioimmunotherapy (CHOP-RIT). IV, intravenous.